 | | 2OY | | 表記: | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide (Bound Form) | | 組成式: | C14 H23 Cl N2 O3 S | | SMILES: | O=S(=O)(NC(CCCCN)C(O)CCl)c1ccc(cc1)C | | InChi: | InChI=1S/C14H23ClN2O3S/c1-11-5-7-12(8-6-11)21(19,20)17-13(14(18)10-15)4-2-3-9-16/h5-8,13-14,17-18H,2-4,9-10,16H2,1H3/t13-,14+/m0/s1 | | 別名: | Tosyllysine Chloromethyl Ketone (Bound Form) | | 定義日: | 2013-12-19 | | 最終更新日: | 2024-09-27 | | 公開日: | 2014-04-23 | | 識別子（ID）: | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide |
|
 | | DLS | | 表記: | DI-ACETYL-LYSINE | | 組成式: | C10 H18 N2 O4 | | SMILES: | O=C(NC(C(=O)O)CCCCNC(=O)C)C | | InChi: | InChI=1S/C10H18N2O4/c1-7(13)11-6-4-3-5-9(10(15)16)12-8(2)14/h9H,3-6H2,1-2H3,(H,11,13)(H,12,14)(H,15,16)/t9-/m0/s1 | | 定義日: | 2000-10-11 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | N~2~,N~6~-diacetyl-L-lysine |
|
 | | 2P2 | | 表記: | 1-[(2R,5S)-2-tert-butyl-5-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one | | 組成式: | C25 H38 N2 O4 | | SMILES: | O=C(N2C(C(=O)N1C(C(O)CO)CCC1)CCC2C(C)(C)C)CCCc3ccccc3 | | InChi: | InChI=1S/C25H38N2O4/c1-25(2,3)22-15-14-20(24(31)26-16-8-12-19(26)21(29)17-28)27(22)23(30)13-7-11-18-9-5-4-6-10-18/h4-6,9-10,19-22,28-29H,7-8,11-17H2,1-3H3/t19-,20-,21-,22+/m0/s1 | | 定義日: | 2012-03-15 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (1R)-1-{(2S)-1-[(5R)-5-tert-butyl-1-(4-phenylbutanoyl)-L-prolyl]pyrrolidin-2-yl}ethane-1,2-diol |
|
 | | 2P3 | | 表記: | 5-[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione | | 組成式: | C10 H9 N3 O2 S | | SMILES: | S=C1NN=C(N1)C2Oc3ccccc3OC2 | | InChi: | InChI=1S/C10H9N3O2S/c16-10-11-9(12-13-10)8-5-14-6-3-1-2-4-7(6)15-8/h1-4,8H,5H2,(H2,11,12,13,16)/t8-/m1/s1 | | 定義日: | 2013-12-23 | | 最終更新日: | 2024-09-27 | | 公開日: | 2014-08-20 | | 識別子（ID）: | 5-[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione |
|
 | | 2P4 | | 表記: | (5R)-N-benzyl-5-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)cyclopent-1-ene-1-carboxamide | | 組成式: | C20 H26 N2 O4 | | SMILES: | O=C(N1C(C(O)CO)CCC1)C3C(C(=O)NCc2ccccc2)=CCC3 | | InChi: | InChI=1S/C20H26N2O4/c23-13-18(24)17-10-5-11-22(17)20(26)16-9-4-8-15(16)19(25)21-12-14-6-2-1-3-7-14/h1-3,6-8,16-18,23-24H,4-5,9-13H2,(H,21,25)/t16-,17+,18+/m1/s1 | | 定義日: | 2012-03-15 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (5R)-N-benzyl-5-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)cyclopent-1-ene-1-carboxamide |
|
 | | DM0 | | 表記: | N~2~,N~2~,N~6~,N~6~-tetramethyl-L-lysine | | 組成式: | C10 H22 N2 O2 | | SMILES: | O=C(O)C(N(C)C)CCCCN(C)C | | InChi: | InChI=1S/C10H22N2O2/c1-11(2)8-6-5-7-9(10(13)14)12(3)4/h9H,5-8H2,1-4H3,(H,13,14)/t9-/m0/s1 | | 定義日: | 2008-03-25 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | N~2~,N~2~,N~6~,N~6~-tetramethyl-L-lysine |
|
 | | 2P8 | | 表記: | (2S)-N-benzyl-2-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)pyrrolidine-1-carboxamide | | 組成式: | C19 H27 N3 O4 | | SMILES: | O=C(N1C(C(O)CO)CCC1)C3N(C(=O)NCc2ccccc2)CCC3 | | InChi: | InChI=1S/C19H27N3O4/c23-13-17(24)15-8-4-10-21(15)18(25)16-9-5-11-22(16)19(26)20-12-14-6-2-1-3-7-14/h1-3,6-7,15-17,23-24H,4-5,8-13H2,(H,20,26)/t15-,16-,17-/m0/s1 | | 定義日: | 2012-03-15 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | (2S)-N-benzyl-2-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)pyrrolidine-1-carboxamide |
|
 | | 2PB | | 表記: | 2-[(DIOXIDOPHOSPHINO)OXY]BENZOATE | | 組成式: | C7 H5 O5 P | | SMILES: | O=P([O-])Oc1ccccc1C([O-])=O | | InChi: | InChI=1S/C7H7O5P/c8-7(9)5-3-1-2-4-6(5)12-13(10)11/h1-4,13H,(H,8,9)(H,10,11)/p-2 | | 定義日: | 2004-03-26 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 2-[(dioxidophosphanyl)oxy]benzoate |
|
 | | DMG | | 表記: | N,N-DIMETHYLGLYCINE | | 組成式: | C4 H9 N O2 | | SMILES: | O=C(O)CN(C)C | | InChi: | InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7) | | 別名: | DIMETHYLGLYCINE | | 定義日: | 2000-03-20 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | N,N-dimethylglycine |
|
 | | DMH | | 表記: | N4,N4-DIMETHYL-ASPARAGINE | | 組成式: | C6 H12 N2 O3 | | SMILES: | O=C(N(C)C)CC(N)C(=O)O | | InChi: | InChI=1S/C6H12N2O3/c1-8(2)5(9)3-4(7)6(10)11/h4H,3,7H2,1-2H3,(H,10,11)/t4-/m0/s1 | | 定義日: | 2001-08-24 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | N,N-dimethyl-L-asparagine |
|
 | | 2PP | | 表記: | 2-PROPYL-PENTANOIC ACID | | 組成式: | C8 H16 O2 | | SMILES: | O=C(O)C(CCC)CCC | | InChi: | InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10) | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 2-propylpentanoic acid |
|
 | | DMK | | 表記: | 3,3-DIMETHYL ASPARTIC ACID | | 組成式: | C6 H11 N O4 | | SMILES: | NC(C(C(O)=O)(C)C)C(=O)O | | InChi: | InChI=1S/C6H11NO4/c1-6(2,5(10)11)3(7)4(8)9/h3H,7H2,1-2H3,(H,8,9)(H,10,11)/t3-/m1/s1 | | 定義日: | 2003-01-30 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 3,3-dimethyl-L-aspartic acid |
|
 | | DMO | | 表記: | ALPHA-DIFLUOROMETHYLORNITHINE | | 組成式: | C6 H12 F2 N2 O2 | | SMILES: | FC(F)C(N)(C(=O)O)CCCN | | InChi: | InChI=1S/C6H12F2N2O2/c7-4(8)6(10,5(11)12)2-1-3-9/h4H,1-3,9-10H2,(H,11,12)/t6-/m1/s1 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 2-(difluoromethyl)-L-ornithine |
|
 | | DMS | | 表記: | DIMETHYL SULFOXIDE | | 組成式: | C2 H6 O S | | SMILES: | sulfinyldimethane | | InChi: | InChI=1S/C2H6OS/c1-4(2)3/h1-2H3 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | dimethyl sulfoxide |
|
 | | DMT | | 表記: | 3-HYDROXY-4,4-DIMETHYL-2-(METHYLAMINO)-6-OCTENOIC ACID | | 組成式: | C11 H21 N O3 | | SMILES: | O=C(O)C(NC)C(O)C(C/C=C/C)(C)C | | InChi: | InChI=1S/C11H21NO3/c1-5-6-7-11(2,3)9(13)8(12-4)10(14)15/h5-6,8-9,12-13H,7H2,1-4H3,(H,14,15)/b6-5+/t8-,9-/m0/s1 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 4-[(2E)-but-2-en-1-yl]-2,4,5-trideoxy-4-methyl-2-(methylamino)-D-arabinonic acid |
|
 | | 2Q7 | | 表記: | N-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-1-(prop-2-enoyl)piperidine-4-carboxamide | | 組成式: | C27 H35 F2 N11 O4 | | SMILES: | C=CC(=O)N1CCC(CC1)C(=O)NCC(=O)N1CCN(CC1)c1nc(nc(n1)c1cnc(N)nc1C(F)F)N1CCOCC1 | | InChi: | InChI=1S/C27H35F2N11O4/c1-2-19(41)37-5-3-17(4-6-37)24(43)31-16-20(42)38-7-9-39(10-8-38)26-34-23(18-15-32-25(30)33-21(18)22(28)29)35-27(36-26)40-11-13-44-14-12-40/h2,15,17,22H,1,3-14,16H2,(H,31,43)(H2,30,32,33) | | 定義日: | 2021-06-30 | | 最終更新日: | 2024-09-27 | | 公開日: | 2022-04-06 | | 識別子（ID）: | N-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-1-(prop-2-enoyl)piperidine-4-carboxamide |
|
 | | DN1 | | 表記: | 3-({(2S)-2-[({(1R)-1-[({(1R)-1-[(R)-CARBOXY(HYDROXY)METHYL]-3,3-DIFLUOROPROPYL}AMINO)CARBONYL]-3-METHYLBUTYL}AMINO)CARB
ONYL]-2,3-DIHYDRO-1H-INDOL-2-YL}METHYL)THIOPHENE-2-CARBOXYLIC ACID | | 組成式: | C26 H31 F2 N3 O7 S | | SMILES: | O=C(O)C(O)C(NC(=O)C(NC(=O)C2(Nc1ccccc1C2)Cc3c(scc3)C(=O)O)CC(C)C)CC(F)F | | InChi: | InChI=1S/C26H31F2N3O7S/c1-13(2)9-18(22(33)29-17(10-19(27)28)20(32)23(34)35)30-25(38)26(11-14-5-3-4-6-16(14)31-26)12-15-7-8-39-21(15)24(36)37/h3-8,13,17-20,31-32H,9-12H2,1-2H3,(H,29,33)(H,30,38)(H,34,35)(H,36,37)/t17-,18-,20-,26+/m1/s1 | | 別名: | PEPTIDOMIMETIC INHIBITOR | | 定義日: | 2004-07-14 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 3-{[N-({(2S)-2-[(2-carboxythiophen-3-yl)methyl]-2,3-dihydro-1H-indol-2-yl}carbonyl)-D-leucyl]amino}-3,4,5-trideoxy-5,5-difluoro-D-erythro-pentonic acid |
|
 | | DN2 | | 表記: | 3-({(2S)-2-[({(1S)-1-[({(1S)-1-[(R)-CARBOXY(HYDROXY)METHYL]-3,3-DIFLUOROPROPYL}AMINO)CARBONYL]-3-METHYLBUTYL}AMINO)CARBONYL]-2,3-DIHYDRO-1H-INDOL-2-YL}METHYL)THIOPHENE-2-CARBOXYLIC ACID | | 組成式: | C26 H31 F2 N3 O7 S | | SMILES: | O=C(O)C(O)C(NC(=O)C(NC(=O)C2(Nc1ccccc1C2)Cc3c(scc3)C(=O)O)CC(C)C)CC(F)F | | InChi: | InChI=1S/C26H31F2N3O7S/c1-13(2)9-18(22(33)29-17(10-19(27)28)20(32)23(34)35)30-25(38)26(11-14-5-3-4-6-16(14)31-26)12-15-7-8-39-21(15)24(36)37/h3-8,13,17-20,31-32H,9-12H2,1-2H3,(H,29,33)(H,30,38)(H,34,35)(H,36,37)/t17-,18-,20+,26-/m0/s1 | | 別名: | PEPTIDOMIMETIC INHIBITOR | | 定義日: | 2004-07-14 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 3-{[N-({(2S)-2-[(2-carboxythiophen-3-yl)methyl]-2,3-dihydro-1H-indol-2-yl}carbonyl)-L-leucyl]amino}-3,4,5-trideoxy-5,5-difluoro-L-threo-pentonic acid |
|
 | | DNE | | 表記: | D-NORLEUCINE | | 組成式: | C6 H13 N O2 | | SMILES: | O=C(O)C(N)CCCC | | InChi: | InChI=1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m1/s1 | | 定義日: | 2003-11-14 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | D-norleucine |
|
 | | DNG | | 表記: | N-FORMYL-D-NORLEUCINE | | 組成式: | C7 H13 N O3 | | SMILES: | O=CNC(C(=O)O)CCCC | | InChi: | InChI=1S/C7H13NO3/c1-2-3-4-6(7(10)11)8-5-9/h5-6H,2-4H2,1H3,(H,8,9)(H,10,11)/t6-/m1/s1 | | 定義日: | 2004-01-27 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | N-formyl-D-norleucine |
|
 | | DNM | | 表記: | N-methyl-D-norleucine | | 組成式: | C7 H15 N O2 | | SMILES: | C(C(NC)CCCC)(=O)O | | InChi: | InChI=1S/C7H15NO2/c1-3-4-5-6(8-2)7(9)10/h6,8H,3-5H2,1-2H3,(H,9,10)/t6-/m1/s1 | | 定義日: | 2003-11-17 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | N-methyl-D-norleucine |
|
 | | DNP | | 表記: | 3-AMINO-ALANINE | | 組成式: | C3 H9 N2 O2 | | SMILES: | O=C(O)C(N)C[NH3+] | | InChi: | InChI=1S/C3H8N2O2/c4-1-2(5)3(6)7/h2H,1,4-5H2,(H,6,7)/p+1/t2-/m0/s1 | | 定義日: | 1999-07-08 | | 最終更新日: | 2024-09-27 | | 識別子（ID）: | 3-ammonio-L-alanine |
|
 | | 2QY | | 表記: | (2Z)-3-(4-hydroxyphenyl)-2-(methylamino)prop-2-enoic acid | | 組成式: | C10 H11 N O3 | | SMILES: | O=C(O)/C(=C/c1ccc(O)cc1)NC | | InChi: | InChI=1S/C10H11NO3/c1-11-9(10(13)14)6-7-2-4-8(12)5-3-7/h2-6,11-12H,1H3,(H,13,14)/b9-6- | | 定義日: | 2014-01-09 | | 最終更新日: | 2024-09-27 | | 公開日: | 2014-04-02 | | 識別子（ID）: | (2Z)-3-(4-hydroxyphenyl)-2-(methylamino)prop-2-enoic acid |
|
 | | 2QZ | | 表記: | N,N-dimethyl-L-threonine | | 組成式: | C6 H13 N O3 | | SMILES: | O=C(O)C(N(C)C)C(O)C | | InChi: | InChI=1S/C6H13NO3/c1-4(8)5(6(9)10)7(2)3/h4-5,8H,1-3H3,(H,9,10)/t4-,5+/m1/s1 | | 定義日: | 2014-01-10 | | 最終更新日: | 2024-09-27 | | 公開日: | 2014-04-02 | | 識別子（ID）: | N,N-dimethyl-L-threonine |
|
 | | 2R1 | | 表記: | (2E)-2-amino-4-hydroxy-3-[(2R)-oxiran-2-yl]but-2-enoic acid | | 組成式: | C6 H9 N O4 | | SMILES: | O=C(O)/C(N)=C(/CO)C1OC1 | | InChi: | InChI=1S/C6H9NO4/c7-5(6(9)10)3(1-8)4-2-11-4/h4,8H,1-2,7H2,(H,9,10)/b5-3+/t4-/m0/s1 | | 定義日: | 2014-01-10 | | 最終更新日: | 2024-09-27 | | 公開日: | 2014-04-02 | | 識別子（ID）: | (2E)-2-amino-4-hydroxy-3-[(2R)-oxiran-2-yl]but-2-enoic acid |
|
